ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

31,422Medicare Part D Prescriptions Filled, Including Refills

Rank: 55 out of 3647

$1.03M Total Retail Price of All Prescriptions

Rank: 204 out of 3647

1,107 Patients Receiving at Least One Drug in Part D
72%Patients 65 Years and Older
36% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

16% of this provider’s 1,107 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

15% of this provider’s 1,107 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

2% of this provider’s 21,758 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

15% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$33 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
LISINOPRIL 1,974 1,494 1 4
AMLODIPINE BESYLATE 1,374 1,122 2 2
OMEPRAZOLE 1,228 842 3 3
SIMVASTATIN 1,199 895 4 1
LEVOTHYROXINE SODIUM 1,177 916 5 5
METFORMIN HCL 1,162 842 6 6
PRAVASTATIN SODIUM 899 684 7 16
FUROSEMIDE 787 663 8 8
METOPROLOL TARTRATE 622 502 9 7
LOSARTAN POTASSIUM 579 486 10 11
GABAPENTIN 555 332 11 17
FLUOXETINE HCL 538 286 12 68
HYDROCODONE-ACETAMINOPHEN 519 286 S3 13 12
ATENOLOL 485 395 14 10
ZOLPIDEM TARTRATE 474 290 15 14
TRAMADOL HCL 403 256 16 22
FINASTERIDE 394 328 17 66
CHLORTHALIDONE 366 309 18 208
POTASSIUM CHLORIDE 350 280 19 24
LOVASTATIN 340 297 20 21
GLIMEPIRIDE 319 253 21 45
TIZANIDINE HCL 312 190 22 126
TERAZOSIN HCL 292 248 23 103
ALPRAZOLAM 290 158 24 31
CITALOPRAM HBR 283 154 25 25
OXYCODONE HCL 278 83 S2 26 75
OXYCODONE-ACETAMINOPHEN 272 140 S2 27 91
CARVEDILOL 271 199 28 20
HYDROCHLOROTHIAZIDE 269 227 29 9
PREDNISONE 256 167 30 43
SERTRALINE HCL 235 186 31 27
ISOSORBIDE MONONITRATE ER 213 159 32 56
WARFARIN SODIUM 213 168 32 15
IBUPROFEN 204 118 34 55
SPIRONOLACTONE 199 129 35 77
LISINOPRIL-HYDROCHLOROTHIAZIDE 180 146 36 36
TRAZODONE HCL 174 76 37 64
TEMAZEPAM 174 144 37 47
AMOX TR-POTASSIUM CLAVULANATE 171 110 39 118
CLONIDINE HCL 170 94 40 46
DICLOFENAC SODIUM 169 125 41 86
FENOFIBRATE 169 95 41 50
CIPROFLOXACIN HCL 159 105 43 53
LABETALOL HCL 158 138 44 172
CYCLOBENZAPRINE HCL 157 72 R 45 98
ALENDRONATE SODIUM 150 130 46 23
INSULIN SYRINGE 149 93 47 76
BACLOFEN 144 79 48 97
GLYBURIDE 136 129 R 49 54
PANTOPRAZOLE SODIUM 133 64 50 38
VENTOLIN HFA 132 61 51 88
CLOPIDOGREL 132 87 51 26
METOPROLOL SUCCINATE 129 92 53 18
OXYBUTYNIN CHLORIDE 128 117 54 107
TAMSULOSIN HCL 127 104 55 28
METHADONE HCL 126 0 S2 56 174
MORPHINE SULFATE ER 118 35 S2 57 163
ATORVASTATIN CALCIUM 115 78 58 13
CARISOPRODOL 115 32 R 58 115
ENALAPRIL MALEATE 114 100 60 35
PAROXETINE HCL 114 63 60 60
GLIPIZIDE 108 93 62 41
MECLIZINE HCL 106 80 63 85
ESTRADIOL 105 78 R 64 236
SYNTHROID 103 76 65 42
RANITIDINE HCL 101 69 66 29
NABUMETONE 100 72 67 262
DIGOXIN 99 99 68 51
CARBIDOPA-LEVODOPA 93 56 69 127
PROAIR HFA 92 50 70 62
ALLOPURINOL 91 79 71 37
DONEPEZIL HCL 90 81 72 30
METHYLDOPA 90 75 R 72 525
AMITRIPTYLINE HCL 90 44 R 72 105
OXYCODONE HCL-ACETAMINOPHEN 89 28 S2 75 104
VERAPAMIL ER 88 76 76 99
METHOTREXATE 88 48 76 224
FAMOTIDINE 86 62 78 61
MELOXICAM 86 64 78 33
RISPERIDONE 84 25 80 83
ACETAMINOPHEN-CODEINE 81 68 S3 81 149
PLAVIX 80 56 82 39
FLUTICASONE PROPIONATE 79 45 83 32
SPIRIVA 74 40 84 93
TRIAMCINOLONE ACETONIDE 72 45 85 136
CLARITHROMYCIN 71 48 86 431
NAPROXEN 70 48 87 70
KLOR-CON 10 69 48 88 106
LANTUS 68 60 89 59
CYMBALTA 67 13 90 79
PROPRANOLOL HCL 66 48 91 156
SULFAMETHOXAZOLE-TRIMETHOPRIM 65 40 92 110
SUCRALFATE 65 31 92 219
DICLOFENAC POTASSIUM 64 44 94 376
METOCLOPRAMIDE HCL 63 43 95 135
METRONIDAZOLE 63 39 95 247
ROPINIROLE HCL 62 26 97 151
FOLIC ACID 62 58 97 95
BUPROPION HCL SR 61 15 99 249
DOXAZOSIN MESYLATE 60 56 100 57
FLUOCINONIDE 58 47 101 369
POLYETHYLENE GLYCOL 3350 57 37 102 143
DOXYCYCLINE HYCLATE 57 37 102 145
LEVETIRACETAM 55 17 104 122
CARBAMAZEPINE 55 26 104 308
VENLAFAXINE HCL ER 54 19 106 181
CILOSTAZOL 54 29 106 168
LORAZEPAM 54 31 106 73
CLONAZEPAM 53 22 109 146
TRIAMTERENE-HCTZ 53 47 109 58
HYDRALAZINE HCL 53 42 109 81
MIRTAZAPINE 52 45 112 63
LOSARTAN-HYDROCHLOROTHIAZIDE 52 39 112 48
DULERA 51 23 114 572
TESTOSTERONE CYPIONATE 50 27 S3 115 280
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 3, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.